NCT06787625 Development of Organoids From Primary Colorectal Tumors and Synchronous Liver Metastases
| NCT ID | NCT06787625 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Regina Elena Cancer Institute |
| Condition | Colo-rectal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 10 participants |
| Start Date | 2024-05-25 |
| Primary Completion | 2028-01-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10 participants in total. It began in 2024-05-25 with a primary completion date of 2028-01-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Pilot feasibility study for the development of organoids from primary colorectal tumors and synchronous liver metastases, to prepare organoids from primary colorectal tumors and synchronous liver metastases. The organoids will allow us to study the function of genes targeted by the activity of the NF-Y/p53 complex.
Eligibility Criteria
Inclusion Criteria: * Patients \> 18 years * Histological and cytological diagnosis of colorectal cancer neoplasia that has developed a liver metastasis * Patients who are candidates for surgery for colorectal cancer with liver metastasis * Signing of the relevant informed consent form. Exclusion Criteria: * All exclusion criteria adopted in surgical protocols will be applied to the study
Contact & Investigator
Giulia Piaggio, Biologist
PRINCIPAL INVESTIGATOR
IRCCS National Cancer Institute
Frequently Asked Questions
Who can join the NCT06787625 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colo-rectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06787625 currently recruiting?
Yes, NCT06787625 is actively recruiting participants. Contact the research team at gialia.piaggio@ifo.it for enrollment information.
Where is the NCT06787625 trial being conducted?
This trial is being conducted at Rome, Italy.
Who is sponsoring the NCT06787625 clinical trial?
NCT06787625 is sponsored by Regina Elena Cancer Institute. The principal investigator is Giulia Piaggio, Biologist at IRCCS National Cancer Institute. The trial plans to enroll 10 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.